Effect of a marine extract in healthy middle-aged wome

Not Applicable

Active, not recruiting

• Conditions: Body composition; Muscular strength; Musculoskeletal - Normal musculoskeletal and cartilage development and function

• Registration Number: ACTRN12622001061729
• Lead Sponsor: Pharmalink International Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-29
• Last Update Posted: 9 October 2023

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Female
• Target Recruitment: 61

Inclusion Criteria

Pre- and post menopausal women
Not physically or mentally impacted by a severe acute or chronic medical condition
Persons with Type 2 diabetes, well-controlled with or without medication, for greater than six months, will be eligible
Persons on stable blood pressure or lipid medication for greater than three months will be eligible as long there is no diagnosis of a major cardiovascular disease.
BMI greater than 18 and less than 35

Exclusion Criteria

Women with osteoporosis
Peri-menopausal women
Having a pacemaker or other metallic implants
Smokers, including vaping
Allergy to shellfish, green-lipped mussels or Antarctic krill
Pregnant or breast-feeding or planning to become pregnant in the next 6 months.
Alcohol or drug addiction.
Inability to cease taking current alternative medicines for the duration of the trial.
Persons with kidney disease or impaired kidney function
Persons with oedema
Persons with severe vertigo

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body composition measured by multi-frequency bioelectrical impedance - Tanita MC980. Body composition measurements will include fat free mass, muscle mass, body fat, total body water, extracellular water, as well as resistance and reactance[ Baseline, and 12 weeks and 26 weeks post commencement of intervention. Primary timepoint will be 12 weeks.]